Eli Lilly Keeps Spending. Its Core Business Has a Growing Problem.
The Merida deal adds to a $20 billion acquisition spree, but employer GLP-1 coverage is contracting and the market is…
September 2026
CME Group Is the Stock to Own While the Fed Debate Rages
September hike odds rose from 35% to 58% in three sessions. CME's rates business earns on every tick of that…